Taking the next step in cardiovascular risk reduction: Integrating heart failure and peripheral arterial disease prevention

被引：1
|
作者：
Matasic, Daniel S. [1 ]
Blumenthal, Roger S. [1 ]
Fonarow, Gregg C. [2 ]
Gulati, Martha [3 ,4 ]
机构：
[1] Johns Hopkins Univ, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Dis, Div Cardiol, Baltimore, MD USA
[2] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA
[3] Cedars Sinai Smidt Heart Inst, Barbra Streisand Womens Heart Ctr, Dept Cardiol, Los Angeles, CA USA
[4] Smidt Heart Inst, Cedars Sinai Med Ctr, Barbra Streisand Womens Heart Ctr, 127 S San Vicente Blvd,Suite A3600, Los Angeles, CA 90048 USA
来源：
AMERICAN HEART JOURNAL | 2023年 / 266卷
关键词：
D O I：
10.1016/j.ahj.2023.07.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：176 / 178
页数：3
相关论文
共 50 条
  • [41] Control of cardiovascular risk factors in peripheral arterial disease patients in the REduction in atherothrombosis for continued health (REACH) registry
    Cacoub, Patrice
    Abola, M. T.
    Baumgartner, Iris
    Bhatt, Deepak L.
    Creager, Mark A.
    Liau, Chiau-Suong
    Goto, Shinya
    Röther, Joachim
    Hirsch, Alan T.
    CIRCULATION, 2006, 114 (18) : 867 - 867
  • [42] Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention
    Muir, Rachelle L.
    JOURNAL OF VASCULAR NURSING, 2009, 27 (02) : 26 - 30
  • [43] Cardiovascular disease prevention: Risk factor modification at the heart of the matter
    Fawzy, Ameenathul M.
    Lip, Gregory Y. H.
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2021, 17
  • [44] Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?
    Thau, Henriette
    Neuber, Sebastian
    Emmert, Maximilian Y.
    Nazari-Shafti, Timo Z.
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 39 - 67
  • [45] Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?
    Henriette Thau
    Sebastian Neuber
    Maximilian Y. Emmert
    Timo Z. Nazari-Shafti
    Cardiology and Therapy, 2024, 13 : 39 - 67
  • [46] Abdominal fat and risk of coronary heart disease in patients with peripheral arterial disease
    Brouwer, Beate G.
    Visseren, Frank L. J.
    Stolk, Ronald P.
    van der Graaf, Yolanda
    OBESITY, 2007, 15 (06) : 1623 - 1630
  • [47] Cardiovascular disease risk factors in congenital heart disease survivors are associated with heart failure
    Landstrom, Andrew P.
    Spears, Tracy
    D'Ottavio, Alfred
    Chiswell, Karen
    Sommerhalter, Kristin
    Soim, Aida
    Farr, Sherry L.
    Crume, Tessa
    Book, Wendy M.
    Whitehead, Kevin
    Botto, Lorenzo D.
    Li, Jennifer S.
    Hsu, Daphne T.
    PEDIATRIC RESEARCH, 2024,
  • [48] Primary prevention of coronary heart disease - Integrating risk assessment with intervention
    Grundy, SM
    CIRCULATION, 1999, 100 (09) : 988 - 998
  • [49] Digital Peripheral Arterial Tonometry and Cardiovascular Disease Events The Framingham Heart Study
    Cooper, Leroy L.
    Wang, Na
    Beiser, Alexa S.
    Romero, Jose Rafael
    Aparicio, Hugo J.
    Lioutas, Vasileios-Arsenios
    Benjamin, Emelia J.
    Larson, Martin G.
    Vasan, Ramachandran S.
    Mitchell, Gary F.
    Seshadri, Sudha
    Hamburg, Naomi M.
    STROKE, 2021, 52 (09) : 2866 - 2873
  • [50] Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study
    Brevetti, Gregorio
    Schiano, Vittorio
    Verdoliva, Sebastiano
    Silvestro, Antonio
    Sirico, Giusy
    De Maio, Julieta
    Lanero, Simona
    Chiariello, Massimo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2006, 7 (08) : 608 - 613
12345